Abstract:Current therapeutic strategies for ischemic stroke fall short of the desired objective of neurological functional recovery. Therefore, there is an urgent need to develop new methods for the treatment of this condition. Exosomes are natural cell-derived vesicles that mediate signal transduction between cells under physiological and pathological conditions. They have low immunogenicity, good stability, high delivery efficiency, and the ability to cross the blood-brain barrier. These physiological properties of exosomes have the potential to lead to new breakthroughs in the treatment of ischemic stroke. The rapid development of nanotechnology has advanced the application of engineered exosomes, which can effectively improve targeting ability, enhance therapeutic efficacy, and minimize the dosages needed. Advances in technology have also driven clinical translational research on exosomes. In this review, we describe the therapeutic effects of exosomes and their positive roles in current treatment strategies for ischemic stroke, including their anti-inflammation, anti-apoptosis, autophagy-regulation, angiogenesis, neurogenesis, and glial scar formation reduction effects. However, it is worth noting that, despite their significant therapeutic potential, there remains a dearth of standardized characterization methods and efficient isolation techniques capable of producing highly purified exosomes. Future optimization strategies should prioritize the exploration of suitable isolation techniques and the establishment of unified workflows to effectively harness exosomes for diagnostic or therapeutic applications in ischemic stroke. Ultimately, our review aims to summarize our understanding of exosome-based treatment prospects in ischemic stroke and foster innovative ideas for the development of exosome-based therapies.

Functional Roles of Mesenchymal Stem Cell-derived Exosomes in Ischemic Stroke Treatment

Exosomes Derived From Mesenchymal Stem Cells: Novel Effects in the Treatment of Ischemic Stroke

Exosomes-based therapy of stroke, an emerging approach toward recovery

Extracellular Vesicles in Mesenchymal Stromal Cells: A Novel Therapeutic Strategy for Stroke (Review)

Mesenchymal stem cell-derived exosomes: Shaping the next era of stroke treatment

Potential of Exosomes for the Treatment of Stroke

Emerging Roles of Exosomes in Stroke Therapy

The Therapeutic Potential of Mesenchymal Stem Cell–Derived Exosomes in Treatment of Neurodegenerative Diseases

Emerging role of mesenchymal stromal cells (MSCs)-derived exosome in neurodegeneration-associated conditions: a groundbreaking cell-free approach

Mesenchymal stem cells and their extracellular vesicles as emerging therapeutic tools in the treatment of ischemic stroke

Detailed role of mesenchymal stem cell (MSC)-derived exosome therapy in cardiac diseases

Exosomes from bone marrow mesenchymal stem cells are a potential treatment for ischemic stroke

The exo‐microRNA (miRNA) signaling pathways in pathogenesis and treatment of stroke diseases: Emphasize on mesenchymal stem cells (MSCs)

Mesenchymal stem cell-derived exosomes as a new therapeutic strategy in the brain tumors

Exosomes: the Next-Generation Therapeutic Platform for Ischemic Stroke

Mesenchymal stem cell-derived exosome microRNA as therapy for cardiac ischemic injury

Novel Therapeutic Applications of Stem Cell-Derived Exosomes in Enhancing Neurological Regeneration and Repair

Therapeutic properties of stem cell-derived exosomes in ischemic heart disease

Mesenchymal Stem Cell-Derived Extracellular Vesicle Therapy for Stroke: Challenges and Progress

Emerging Role of Mesenchymal Stem Cell-derived Exosomes in Regenerative Medicine

Engineered exosomes enriched with select microRNAs amplify their therapeutic efficacy for traumatic brain injury and stroke